Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.

Less than $10/month! Screen on your Watchlists and Portfolios with Barchart Plus. FREE 30 Day Trial

Faster, Cleaner, Better.

Aprea Therapeutics Inc (APRE)

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]

[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]

[[ session ]] by (Cboe BZX)

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]

[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]

[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]

Cash Flow for [[ item.sessionDateDisplayLong ]]

Fiscal Year End Date: 12/31

(Values in U.S. thousands)

	12-2020	12-2019	12-2018	12-2017	12-2006
Cash Flows From Operating Activities
Net Income	-53,479	-28,060	-15,528	-15,190	N/A
Depreciation Amortization	230	170	8	8	N/A
Accounts payable and accrued liabilities	2,327	438	214	327	N/A
Other Working Capital	5,573	1,163	902	1,447	N/A
Other Operating Activity	3,546	-420	-847	-594	0
Operating Cash Flow	$-41,803	$-26,709	$-15,250	$-14,002	$N/A

Cash Flows From Investing Activities
PPE Investments	-26	-31	-4	N/A	N/A
Investing Cash Flow	$-26	$-31	$-4	$N/A	$N/A

Cash Flows From Financing Activities
Common Stock Issued	151	86,977	2	N/A	N/A
Other Financing Activity	0	5,598	56,365	23,344	0
Financing Cash Flow	$151	$92,576	$56,367	$23,344	$N/A

Exchange Rate Effect	606	-1,423	162	1,395	N/A
Beginning Cash Position	130,089	65,676	24,402	13,665	N/A
End Cash Position	89,018	130,089	65,676	24,402	N/A
Net Cash Flow	$-41,071	$64,413	$41,274	$10,736	$N/A

Free Cash Flow
Operating Cash Flow	-41,803	-26,709	-15,250	-14,002	N/A
Capital Expenditure	-26	-31	-4	N/A	N/A
Free Cash Flow	-41,828	-26,740	-15,254	-14,002	0